These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 7631329)

  • 1. Morbidity, mortality, and antihypertensive treatment effects by extent of atherosclerosis in older adults with isolated systolic hypertension.
    Sutton-Tyrrell K; Alcorn HG; Herzog H; Kelsey SF; Kuller LH
    Stroke; 1995 Aug; 26(8):1319-24. PubMed ID: 7631329
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Extent of cardiovascular risk reduction associated with treatment of isolated systolic hypertension.
    Sutton-Tyrrell K; Wildman R; Newman A; Kuller LH
    Arch Intern Med; 2003 Dec 8-22; 163(22):2728-31. PubMed ID: 14662626
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the Systolic Hypertension in the Elderly Program (SHEP). SHEP Cooperative Research Group.
    JAMA; 1991 Jun; 265(24):3255-64. PubMed ID: 2046107
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of diuretic-based antihypertensive treatment on cardiovascular disease risk in older diabetic patients with isolated systolic hypertension. Systolic Hypertension in the Elderly Program Cooperative Research Group.
    Curb JD; Pressel SL; Cutler JA; Savage PJ; Applegate WB; Black H; Camel G; Davis BR; Frost PH; Gonzalez N; Guthrie G; Oberman A; Rutan GH; Stamler J
    JAMA; 1996 Dec; 276(23):1886-92. PubMed ID: 8968014
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association between chlorthalidone treatment of systolic hypertension and long-term survival.
    Kostis JB; Cabrera J; Cheng JQ; Cosgrove NM; Deng Y; Pressel SL; Davis BR
    JAMA; 2011 Dec; 306(23):2588-93. PubMed ID: 22187278
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of treating isolated systolic hypertension on the risk of developing various types and subtypes of stroke: the Systolic Hypertension in the Elderly Program (SHEP).
    Perry HM; Davis BR; Price TR; Applegate WB; Fields WS; Guralnik JM; Kuller L; Pressel S; Stamler J; Probstfield JL
    JAMA; 2000 Jul; 284(4):465-71. PubMed ID: 10904510
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term fatal outcomes in subjects with stroke or transient ischemic attack: fourteen-year follow-up of the systolic hypertension in the elderly program.
    Patel AB; Kostis JB; Wilson AC; Shea ML; Pressel SL; Davis BR
    Stroke; 2008 Apr; 39(4):1084-9. PubMed ID: 18309155
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Blood pressure treatment slows the progression of carotid stenosis in patients with isolated systolic hypertension.
    Sutton-Tyrrell K; Wolfson SK; Kuller LH
    Stroke; 1994 Jan; 25(1):44-50. PubMed ID: 8266382
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Morbidity and mortality in the Systolic Hypertension in the Elderly Program (SHEP) pilot study.
    Perry HM; Smith WM; McDonald RH; Black D; Cutler JA; Furberg CD; Greenlick MR; Kuller LH; Schnaper HW; Schoenberger JA
    Stroke; 1989 Jan; 20(1):4-13. PubMed ID: 2911834
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Isolated systolic hypertension in the elderly: implications of Systolic Hypertension in the Elderly Program (SHEP) for clinical practice and for the ongoing trials.
    Staessen J; Fagard R; Amery A
    J Hum Hypertens; 1991 Dec; 5(6):469-74. PubMed ID: 1791605
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevention of heart failure by antihypertensive drug treatment in older persons with isolated systolic hypertension. SHEP Cooperative Research Group.
    Kostis JB; Davis BR; Cutler J; Grimm RH; Berge KG; Cohen JD; Lacy CR; Perry HM; Blaufox MD; Wassertheil-Smoller S; Black HR; Schron E; Berkson DM; Curb JD; Smith WM; McDonald R; Applegate WB
    JAMA; 1997 Jul; 278(3):212-6. PubMed ID: 9218667
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rationale and design of a randomized clinical trial on prevention of stroke in isolated systolic hypertension. The Systolic Hypertension in the Elderly Program (SHEP) Cooperative Research Group.
    J Clin Epidemiol; 1988; 41(12):1197-208. PubMed ID: 2905387
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension. The Systolic Hypertension in Europe (Syst-Eur) Trial Investigators.
    Staessen JA; Fagard R; Thijs L; Celis H; Arabidze GG; Birkenhäger WH; Bulpitt CJ; de Leeuw PW; Dollery CT; Fletcher AE; Forette F; Leonetti G; Nachev C; O'Brien ET; Rosenfeld J; Rodicio JL; Tuomilehto J; Zanchetti A
    Lancet; 1997 Sep; 350(9080):757-64. PubMed ID: 9297994
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of calcium-channel blockade in older patients with diabetes and systolic hypertension. Systolic Hypertension in Europe Trial Investigators.
    Tuomilehto J; Rastenyte D; Birkenhäger WH; Thijs L; Antikainen R; Bulpitt CJ; Fletcher AE; Forette F; Goldhaber A; Palatini P; Sarti C; Fagard R
    N Engl J Med; 1999 Mar; 340(9):677-84. PubMed ID: 10053176
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Hypertension as a function of age].
    Gensini GF; Corradi F
    Ital Heart J; 2000 Jun; 1 Suppl 2():23-31. PubMed ID: 10905125
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of atenolol and reserpine on selected events in the systolic hypertension in the elderly program (SHEP).
    Kostis JB; Berge KG; Davis BR; Hawkins CM; Probstfield J
    Am J Hypertens; 1995 Dec; 8(12 Pt 1):1147-53. PubMed ID: 8998247
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Change in depression as a precursor of cardiovascular events. SHEP Cooperative Research Group (Systoloc Hypertension in the elderly).
    Wassertheil-Smoller S; Applegate WB; Berge K; Chang CJ; Davis BR; Grimm R; Kostis J; Pressel S; Schron E
    Arch Intern Med; 1996 Mar; 156(5):553-61. PubMed ID: 8604962
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk reduction associated with lowering systolic blood pressure: review of clinical trial data.
    Hall WD
    Am Heart J; 1999 Sep; 138(3 Pt 2):225-30. PubMed ID: 10467217
    [TBL] [Abstract][Full Text] [Related]  

  • 19. First-line drugs inhibiting the renin angiotensin system versus other first-line antihypertensive drug classes for hypertension.
    Xue H; Lu Z; Tang WL; Pang LW; Wang GM; Wong GW; Wright JM
    Cochrane Database Syst Rev; 2015 Jan; 1():CD008170. PubMed ID: 25577154
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictors of cardiovascular events and mortality in the Systolic Hypertension in the Elderly Program pilot project.
    Siegel D; Kuller L; Lazarus NB; Black D; Feigal D; Hughes G; Schoenberger JA; Hulley SB
    Am J Epidemiol; 1987 Sep; 126(3):385-99. PubMed ID: 3303916
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.